Tempest Therapeutics (TPST) Misses Q3 EPS by 79c

Tempest Therapeutics (NASDAQ: TPST) reported Q3 EPS of ($0.79), $0.79 worse than the analyst estimate of $0.00.

For earnings history and earnings-related data on Tempest Therapeutics (TPST) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Western Digital (WDC) call put ratio 1 call to 1.2 puts a focus on January 17.50 puts into Korean market weakness and Micron (MU) quarter results
• Cerebras Systems (CBRS) call put ratio 1 call to 1.1 puts into quarter results